Search Results - "MOREB, J. S"

Refine Results
  1. 1

    Extramedullary disease in plasma cell myeloma: the iceberg phenomenon by Wirk, B, Wingard, J R, Moreb, J S

    Published in Bone marrow transplantation (Basingstoke) (01-01-2013)
    “…Extramedullary (EM) plasmacytomas (EMPs) that are not progression of intramedullary (IM) plasma cell myeloma (PCM) are usually indolent. In contrast, EM spread…”
    Get full text
    Journal Article
  2. 2

    Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw by Katz, J, Gong, Y, Salmasinia, D, Hou, W, Burkley, B, Ferreira, P, Casanova, O, Langaee, T.Y, Moreb, J.S

    “…Abstract Bisphosphonate induced osteonecrosis of the jaw (BONJ) is a complication in patients taking bisphosphonate (BP) that affects their quality of life and…”
    Get full text
    Journal Article
  3. 3

    Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation by MACHADO, M, MOREB, J. S, KHAN, S. A

    Published in Bone marrow transplantation (Basingstoke) (01-11-2007)
    “…Alopecia, a side effect of chemotherapy, is usually temporary and reversible. Irreversible alopecia has been reported after high-dose chemotherapy (HDC) and…”
    Get full text
    Journal Article
  4. 4

    Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital by GROW, W. B, MOREB, J. S, MEHTA, P. S, WINGARD, J. R, ROQUE, D, MANION, K, LEATHER, H, REDDY, V, KHAN, S. A, FINIEWICZ, K. J, NGUYEN, H, CLANCY, C. J

    “…Despite new antifungal treatment strategies, invasive aspergillosis (IA) remains a principal cause of infectious mortality after bone marrow transplantation…”
    Get full text
    Journal Article
  5. 5

    Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma by Gordan, L N, Sugrue, M W, Lynch, J W, Williams, K D, Khan, S A, Moreb, J S

    Published in Bone marrow transplantation (Basingstoke) (01-06-2003)
    “…The importance of the association between early lymphocyte recovery and outcome has not been well studied in autologous stem cell transplantation (ASCT). In…”
    Get full text
    Journal Article
  6. 6

    Gastroparesis following bone marrow transplantation by EAGLE, D. A, GIAN, V, LAUWERS, G. Y, MANIVEL, J. C, MOREB, J. S, MASTIN, S, WINGARD, J. R

    Published in Bone marrow transplantation (Basingstoke) (01-07-2001)
    “…Patients often develop nausea, vomiting and bloating after bone marrow transplantation (BMT). These symptoms may interfere with nutrition and the ability to…”
    Get full text
    Journal Article
  7. 7

    Poor Mobilization of Peripheral Blood Stem Cells is a Risk Factor for Worse Outcome in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation by Gordan, L.N., Sugrue, M.W., Lynch, J.W., Williams, K.D., Khan, S.A., Wingard, J.R., Moreb, J.S.

    Published in Leukemia & lymphoma (01-01-2003)
    “…The effect of poor blood stem cells mobilization on the outcome of autologous stem cell transplantation (ASCT) has not been well studied. Our aim is to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Human A1, a Bcl-2-related gene, is induced in leukemic cells by cytokines as well as differentiating factors by MOREB, J. S, SCHWEDER, M

    Published in Leukemia (01-07-1997)
    “…Based on previously published observations regarding the protective effects of interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF alpha) against gamma…”
    Get full text
    Journal Article
  10. 10

    Continuous Infusion Cyclophosphamide and Low-Dose Total Body Irradiation Is a Safe and Effective Conditioning Regimen for Autologous Transplant in Multiple Myeloma by Byrne, M, Wingard, J.R, Moreb, J.S

    Published in Transplantation proceedings (01-11-2013)
    “…Abstract We present the results of a novel conditioning regimen in multiple myeloma (MM) patients undergoing tandem autologous stem cell transplant (ASCT). MM…”
    Get full text
    Journal Article
  11. 11

    Characterization and Outcome of "Hard to Mobilize" Lymphoma Patients Undergoing Autologous Stem Cell Transplantation by Sugrue, Michele W., Williams, Kathi, Pollock, Brad H., Khan, Shahab, Peracha, Sajid, Wingard, John R., Moreb, Jan S.

    Published in Leukemia & lymphoma (2000)
    “…A "hard to mobilize" patient was defined as one in whom ≥ 1 × 106CD 34, cells/kg cannot be obtained after two consecutive large volume aphereses. Forty-four…”
    Get full text
    Journal Article
  12. 12

    Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients by MOREB, J. S, KUBILIS, P. S, MULLINS, D. L, MYERS, L, YOUNGBLOOD, M, HUTCHESON, C

    Published in Bone marrow transplantation (Basingstoke) (01-01-1997)
    “…In our BMT Unit, we have observed a high frequency of skin rash associated with fever and other clinical findings during engraftment of autologous BM and/or…”
    Get full text
    Journal Article
  13. 13

    Suppression of Spermatogenesis by Bisdichloroacetyldiamines Is Mediated by Inhibition of Testicular Retinoic Acid Biosynthesis by Amory, John K., Muller, Charles H., Shimshoni, Jakob A., Isoherranen, Nina, Paik, Jisun, Moreb, Jan S., Amory, David W., Evanoff, Ryan, Goldstein, Alex S., Griswold, Michael D.

    Published in Journal of andrology (01-01-2011)
    “…The bisdichloroacetyldiamine WIN 18,446 reversibly inhibits spermatogenesis in many species, including humans; however, the mechanism by which WIN 18,446…”
    Get full text
    Journal Article
  14. 14

    Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight by WAPLES, J. M, MOREB, J. S, SUGRUE, M, BELANGER, G, KUBILIS, P, LYNCH, J. W, GIAN, V, WEEKS, F, WINGARD, J

    Published in Bone marrow transplantation (Basingstoke) (01-05-1999)
    “…In this retrospective study, we evaluated the predictability of PBSC dose for hematopoietic engraftment comparing that calculated by ideal body weight (IBW) vs…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Outcome of clinical congestive heart failure induced by anthracycline chemotherapy by Moreb, J S, Oblon, D J

    Published in Cancer (01-12-1992)
    “…Anthracycline-induced congestive heart failure (A-CHF) is associated with a high reported incidence of morbidity and mortality. The long-term clinical outcome…”
    Get more information
    Journal Article
  17. 17

    Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro by Moreb, J S, Maccow, C, Schweder, M, Hecomovich, J

    “…Previous studies in this laboratory showed that the overexpression of human aldehyde dehydrogenase class-1 (ALDH-1) with a retroviral vector resulted in…”
    Get more information
    Journal Article
  18. 18

    In vitro selection for K562 cells with higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclophosphamide by Moreb, J S, Schweder, M, Gray, B, Zucali, J, Zori, R

    Published in Human gene therapy (20-03-1998)
    “…Previously, we have reported the successful expression of human aldehyde dehydrogenase class-1 (ALDH-1) in K562 leukemia cells using a retroviral vector and…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Plerixafor (AMD3100) in myeloma and lymphoma patients undergoing autologous stem cell transplantation by Moreb, J. S., Salmasinia, D., Cline, C., Rosenau, E.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only 7100 Background: Poor peripheral blood stem cell (PBSC) mobilization has been reported as an obstacle to autologous stem cell transplant (ASCT)…”
    Get full text
    Journal Article